rs794727365
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_025074.7(FRAS1):c.2722+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,424,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_025074.7 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAS1 | NM_025074.7 | c.2722+1G>A | splice_donor_variant | ENST00000512123.4 | NP_079350.5 | |||
FRAS1 | NM_001166133.2 | c.2722+1G>A | splice_donor_variant | NP_001159605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.2722+1G>A | splice_donor_variant | 5 | NM_025074.7 | ENSP00000422834 | P1 | |||
FRAS1 | ENST00000325942.11 | c.2722+1G>A | splice_donor_variant | 1 | ENSP00000326330 | |||||
FRAS1 | ENST00000682513.1 | c.2722+1G>A | splice_donor_variant | ENSP00000508201 | ||||||
FRAS1 | ENST00000684159.1 | c.2722+1G>A | splice_donor_variant | ENSP00000506875 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000531 AC: 1AN: 188456Hom.: 0 AF XY: 0.00000996 AC XY: 1AN XY: 100352
GnomAD4 exome AF: 0.0000126 AC: 18AN: 1424880Hom.: 0 Cov.: 31 AF XY: 0.0000156 AC XY: 11AN XY: 705110
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2023 | This sequence change affects a donor splice site in intron 22 of the FRAS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FRAS1 are known to be pathogenic (PMID: 12766769, 18671281). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individual(s) with clinical features of FRAS1 related conditions (PMID: 24551978). ClinVar contains an entry for this variant (Variation ID: 195697). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jul 16, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2014 | - - |
Fraser syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Service de Biochimie Médicale et Biologie Moléculaire, CHU Clermont-Ferrand | Sep 14, 2018 | This variant in homozygous state or compound heterozygous state induced Fraser syndrome phenotype - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at